| Bioactivity | Velpatasvir-13C,d3 (GS-5816-13C,d3) is 13C and deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.16 μM[1][2][3]. |
| Formula | C4813CH51D3N8O8 |
| Molar Mass | 887.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
Velpatasvir-13C,d3
CAS: F: C4813CH51D3N8O8 W: 887.01
Velpatasvir-13C,d3 (GS-5816-13C,d3) is 13C and deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.